[go: up one dir, main page]

TN2010000302A1 - Estradiol-containing drug delivery system - Google Patents

Estradiol-containing drug delivery system

Info

Publication number
TN2010000302A1
TN2010000302A1 TN2010000302A TN2010000302A TN2010000302A1 TN 2010000302 A1 TN2010000302 A1 TN 2010000302A1 TN 2010000302 A TN2010000302 A TN 2010000302A TN 2010000302 A TN2010000302 A TN 2010000302A TN 2010000302 A1 TN2010000302 A1 TN 2010000302A1
Authority
TN
Tunisia
Prior art keywords
estradiol
delivery system
drug delivery
containing drug
active ingredient
Prior art date
Application number
TN2010000302A
Other languages
English (en)
Inventor
Adrian Funke
Sascha General
Iidiko Terebesi
Christian Zurth
Sofia Alincic-Kunz
Matthias Schafers
Thomas Holler
Konstanze Diefenbach
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39365963&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TN2010000302(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of TN2010000302A1 publication Critical patent/TN2010000302A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Reproductive Health (AREA)
  • Physiology (AREA)
  • Psychiatry (AREA)
  • Otolaryngology (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Steroid Compounds (AREA)
TN2010000302A 2008-02-13 2010-06-30 Estradiol-containing drug delivery system TN2010000302A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08002633 2008-02-13
PCT/EP2009/051303 WO2009101021A2 (fr) 2008-02-13 2009-02-05 Système d'administration de médicament contenant de l'estradiol

Publications (1)

Publication Number Publication Date
TN2010000302A1 true TN2010000302A1 (en) 2011-11-11

Family

ID=39365963

Family Applications (1)

Application Number Title Priority Date Filing Date
TN2010000302A TN2010000302A1 (en) 2008-02-13 2010-06-30 Estradiol-containing drug delivery system

Country Status (27)

Country Link
US (1) US20110097405A1 (fr)
EP (1) EP2249803A2 (fr)
JP (1) JP2011511823A (fr)
KR (1) KR20100125309A (fr)
CN (1) CN101945646A (fr)
AR (1) AR070375A1 (fr)
AU (1) AU2009214193A1 (fr)
BR (1) BRPI0908477A2 (fr)
CA (1) CA2714340A1 (fr)
CL (1) CL2009000326A1 (fr)
CO (1) CO6290633A2 (fr)
CR (1) CR11632A (fr)
DO (1) DOP2010000252A (fr)
EA (1) EA201001245A1 (fr)
EC (1) ECSP10010400A (fr)
IL (1) IL206640A0 (fr)
MA (1) MA32073B1 (fr)
MX (1) MX2010008940A (fr)
NZ (1) NZ586666A (fr)
PA (1) PA8816001A1 (fr)
PE (1) PE20091471A1 (fr)
TN (1) TN2010000302A1 (fr)
TW (1) TW200940095A (fr)
UA (1) UA102680C2 (fr)
UY (1) UY31660A1 (fr)
WO (1) WO2009101021A2 (fr)
ZA (1) ZA201006517B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101310710B1 (ko) * 2011-03-23 2013-09-27 한미약품 주식회사 오메가-3 지방산 에스테르 및 ＨＭＧ-ＣｏＡ 환원효소 억제제를 포함하는 경구용 복합 조성물
GB201200062D0 (en) 2012-01-04 2012-02-15 Innotesto Bvba Estradiol oromucosal liquid compositions
WO2014018075A1 (fr) 2012-07-23 2014-01-30 Crayola, Llc Films pouvant être dissous et procédés d'utilisation de ces derniers
US10067103B2 (en) * 2015-03-02 2018-09-04 Colonaryconcepts Llc Compounds and methods for PEG metabolite and PEG breakdown product assays
CN119055659A (zh) * 2024-09-03 2024-12-03 南通大学 17α雌二醇或其化学修饰衍生物在制备预防和/或治疗男性性腺功能低下的药物中的应用

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4136162A (en) * 1974-07-05 1979-01-23 Schering Aktiengesellschaft Medicament carriers in the form of film having active substance incorporated therein
JPS56140915A (en) * 1980-04-07 1981-11-04 Yamanouchi Pharmaceut Co Ltd Pharmaceutical preparation for solid drug
DE3347125A1 (de) * 1983-12-22 1985-07-11 Schering AG, 1000 Berlin und 4709 Bergkamen Mehrstufenkombinationspraeparat und seine verwendung zur oralen kontrazeption
US4764378A (en) * 1986-02-10 1988-08-16 Zetachron, Inc. Buccal drug dosage form
US4800087A (en) * 1986-11-24 1989-01-24 Mehta Atul M Taste-masked pharmaceutical compositions
US5073374A (en) * 1988-11-30 1991-12-17 Schering Corporation Fast dissolving buccal tablet
ATE155681T1 (de) * 1992-05-18 1997-08-15 Minnesota Mining & Mfg Einrichtung zur transmucosalen wirkstoffabgabe
DE4426709A1 (de) * 1994-07-20 1996-01-25 Schering Ag Steroidale Sexualhormone enthaltende feste Arzneiformen
DE19646392A1 (de) * 1996-11-11 1998-05-14 Lohmann Therapie Syst Lts Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht
CH693255A5 (de) * 1997-06-13 2003-05-15 Eprova Ag Verwendung von Tetrahydrofolaten in der natürlichenstereoisomeren Form zur Herstellung einer pharmazeutischenZubereitung geeignet zur Beeinflussung des Homocystein-Spiegels.
CN1240387C (zh) * 1998-04-17 2006-02-08 奥索一麦克尼尔药品公司 含有叶酸的药用组合物及其用途和给药系统
US6552024B1 (en) * 1999-01-21 2003-04-22 Lavipharm Laboratories Inc. Compositions and methods for mucosal delivery
CH693905A5 (de) * 1999-04-15 2004-04-15 Eprova Ag Stabile kristalline Salze von 5-Methyltetrahydrofolsäure.
US6264981B1 (en) * 1999-10-27 2001-07-24 Anesta Corporation Oral transmucosal drug dosage using solid solution
US20030092658A1 (en) * 2001-02-02 2003-05-15 Meyers Rachel E. Novel human enzyme family members and uses thereof
AU5834101A (en) * 2000-04-12 2001-10-23 Schering Ag 8ss-hydrocarbyl-substituted estratrienes for use as selective estrogens
EP1216712A1 (fr) * 2000-12-20 2002-06-26 Schering Aktiengesellschaft Complexes d'inclusion de drospirenone et de cyclodextrines
WO2002092102A2 (fr) * 2001-05-16 2002-11-21 Endeavor Pharmaceuticals Traitement d'etats lies a un deficit en hormones par administration de progestatifs
MXPA03000985A (es) * 2001-07-27 2004-04-02 Yamanouchi Pharma Co Ltd Composicion que comprende particulas finas de liberacion sostenida para tabletas de desintegracion rapida en la cavidad bucal y metodo de fabricacion de la misma.
CA2476940C (fr) * 2002-02-21 2011-11-01 Herman Jan Tijmen Coelingh Bennink Compositions pharmaceutiques contenant un ou plusieurs steroides, un ou plusieurs tetrahydrofolates et de la vitamine b12
DE10207394B4 (de) * 2002-02-21 2007-03-29 Lts Lohmann Therapie-Systeme Ag Geschmacksmaskierte oblatenförmige Arzneizubereitung
WO2005004989A2 (fr) * 2003-07-01 2005-01-20 Todd Maibach Film renfermant des agents therapeutiques
EP1695699A4 (fr) * 2003-12-09 2012-08-22 Dainippon Sumitomo Pharma Co Grains contenant un medicament et preparation solide contenant les grains
MY142989A (en) * 2004-03-10 2011-02-14 Bayer Schering Pharma Ag Stabilised supersaturated solids of lipophilic drugs
US20050220825A1 (en) * 2004-03-10 2005-10-06 Adrian Funke Molecular dispersions of drospirenone
DE102004023984A1 (de) * 2004-05-14 2005-12-08 Hf Arzneimittelforschung Gmbh Filmförmiges, oral zu verabreichendes Arzneimittel, enthaltend Estriol
US20060105038A1 (en) * 2004-11-12 2006-05-18 Eurand Pharmaceuticals Limited Taste-masked pharmaceutical compositions prepared by coacervation
DE102005015128B4 (de) * 2005-03-31 2008-12-11 Bayer Schering Pharma Aktiengesellschaft Wafer enthaltend Steroidhormone
WO2006127879A1 (fr) * 2005-05-26 2006-11-30 Duramed Pharmaceuticals, Inc. Formes pharmaceutiques solides flexibles et procedes d'elaboration et d'utilisation
DE102005058569B4 (de) * 2005-12-08 2010-07-15 Lts Lohmann Therapie-Systeme Ag Schaumwafer mit Polyvinylalkohol-Polyethylenglycol-Pfropfcopolymer
DE102005062270A1 (de) * 2005-12-24 2007-06-28 Bayer Technology Services Gmbh Geschmacksmaskierung von Pulvern
DE102006003512A1 (de) * 2006-01-24 2007-08-02 Bayer Schering Pharma Ag Plättchenförmige Arzneimittel zur transbukkalen Applikation von Arzneistoffen
EP1867321A3 (fr) * 2006-06-07 2008-11-19 Familplan Consulting Ltd. Produit pharmaceutique adapté à l'administration transmucosale orale comportant un agent pharmaceutique
DE102006027792A1 (de) * 2006-06-16 2007-12-20 Lts Lohmann Therapie-Systeme Ag Antidepressiva-Kombinations-Wafer
DE102006027796A1 (de) * 2006-06-16 2007-12-20 Lts Lohmann Therapie-Systeme Ag Estrogen-Gestagen-Kombinationen
US20080058272A1 (en) * 2006-08-29 2008-03-06 Juergen Becker Nonamer Peptides for Cancer Treatment

Also Published As

Publication number Publication date
CO6290633A2 (es) 2011-06-20
WO2009101021A3 (fr) 2009-12-30
ZA201006517B (en) 2014-02-26
NZ586666A (en) 2012-04-27
TW200940095A (en) 2009-10-01
JP2011511823A (ja) 2011-04-14
ECSP10010400A (es) 2010-09-30
AU2009214193A1 (en) 2009-08-20
IL206640A0 (en) 2010-12-30
AR070375A1 (es) 2010-03-31
UA102680C2 (ru) 2013-08-12
CR11632A (es) 2010-10-05
MX2010008940A (es) 2010-10-05
CA2714340A1 (fr) 2009-08-20
KR20100125309A (ko) 2010-11-30
EP2249803A2 (fr) 2010-11-17
PE20091471A1 (es) 2009-10-25
WO2009101021A2 (fr) 2009-08-20
UY31660A1 (es) 2009-09-30
CN101945646A (zh) 2011-01-12
MA32073B1 (fr) 2011-02-01
PA8816001A1 (es) 2009-09-17
CL2009000326A1 (es) 2010-07-19
EA201001245A1 (ru) 2011-04-29
BRPI0908477A2 (pt) 2018-03-27
DOP2010000252A (es) 2010-08-31
US20110097405A1 (en) 2011-04-28

Similar Documents

Publication Publication Date Title
WO2009108077A3 (fr) Composition pharmaceutique destinée à des médicaments peu solubles
EP2522653A4 (fr) Dérivé de biguanide, procédé de préparation de celui-ci et composition pharmaceutique contenant le dérivé de biguanide en tant que substance active
WO2012002640A3 (fr) Système transdermique d'administration de médicament contenant du donépézil
MX353024B (es) Compuestos de fenil carbamato para uso en la prevencion o tratamiento de epilepsia.
PT2043600T (pt) Formulações farmacêuticas para a libertação prolongada de princípio(s) ativo(s), assim como suas aplicações, nomeadamente terapêuticas
PL2081547T3 (pl) Postać galenowa do podawania składników czynnych poprzez śluzówkę
WO2009135593A3 (fr) Formulation pharmaceutique solide à libération retardée
MX359288B (es) Forma iv del clorhidrato de ivabradina.
WO2012032337A3 (fr) Dispositif d'administration de médicament transdermique
WO2012158030A3 (fr) Système d'administration de médicament
WO2011005052A3 (fr) Nouveaux dérivés imidazole-4-carboxamide contenant de l'arylpipérazine et composition pharmaceutique contenant ces dérivés
UA97730C2 (ru) Гербицидные композиции и способ получения гербицидной композиции
TN2010000302A1 (en) Estradiol-containing drug delivery system
MX341015B (es) Forma de dosificacion de liberacion extendida.
WO2006079928A3 (fr) Film polyelectrolytique multicouche, preparation et utilisations de ce film
GB0715493D0 (en) Delivery systems for solubilising water-insoluble pharmaceutical active ingredients
WO2012002773A3 (fr) Composé de phénylcarbamate et relaxant musculaire le contenant
IL201959A (en) Annals 2 - (1-Acetyl-Piperidine-4-Il) -4,2- Dihydro-Pyrazole-3-On
WO2012172433A3 (fr) Composition à libération prolongée contenant des peptides en tant que principes actifs
WO2012111996A3 (fr) Administration transdermique contenant de la galantamine ou ses sels
EP2476420B8 (fr) Composition pharmaceutique à action antimicrobienne et cicatrisante pour application externe, et procédé de fabrication
SI2612681T1 (sl) Obložno sredstvo za farmacevtsko trdno obliko, farmacevtska filmska formulacija in obložena farmacevtska trdna oblika
IL195062A0 (en) Process for the preparation of solid sterile active pharmaceutical ingredient
WO2011159491A3 (fr) Formulations de lévétiracétam à libération contrôlée
TN2010000343A1 (en) Herbicidal composition